Moreover, miR-29b was found downregulated in ovarian cancer and its restoration led to the inhibition of glycolysis and glucose metabolism in cancer cells by targeting AKT2 and AKT3 (65). This evidence concerns the gene AKT2 and ovarian carcinoma.